Opportunities for novel therapeutic agents acting at chemokine receptors
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 4 (2) , 80-92
- https://doi.org/10.1016/s1359-6446(98)01280-x
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Reply from R.C. Connor et al.Trends in Ecology & Evolution, 1998
- 6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7The Journal of cell biology, 1998
- STRL22 Is a Receptor for the CC Chemokine MIP-3αBiochemical and Biophysical Research Communications, 1997
- The chemokine SDF‐1, stromal cell‐derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4European Journal of Immunology, 1997
- Characterization of Synthetic Human Granulocyte Chemotactic Protein 2: Usage of Chemokine Receptors CXCR1 and CXCR2 andin VivoInflammatory PropertiesBiochemistry, 1997
- Assignment of the Human CC Chemokine Gene TARC (SCYA17) to Chromosome 16q13Genomics, 1997
- The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entryNature, 1996
- Mutagenesis Studies of Interleukin-8: IDENTIFICATION OF A SECOND EPITOPE INVOLVED IN RECEPTOR BINDINGPublished by Elsevier ,1996
- Heteronuclear (1H,13C,15N) NMR Assignments and Solution Structure of the Monocyte Chemoattractant Protein-1 (MCP-1) Dimer,Biochemistry, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995